These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7013864)

  • 1. Knowledge acquisition from historical data: application to breast cancer patients.
    Gehan EA; Smith TL; Buzdar AU; Keating MJ; Freireich EJ
    Bull Cancer; 1980; 67(4):437-45. PubMed ID: 7013864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of prognostic factors in analysis of historical control studies.
    Gehan EA; Smith TL; Buzdar AU
    Cancer Treat Rep; 1980; 64(2-3):373-9. PubMed ID: 7407774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
    Nieto Y; Cagnoni PJ; Shpall EJ; Xu X; Murphy J; Vredenburgh J; Chao NJ; Bearman SI; Jones RB
    Clin Cancer Res; 1999 Nov; 5(11):3425-31. PubMed ID: 10589754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869.
    Kute TE; Quadri Y; Muss H; Zbieranski N; Cirrincione C; Berry DA; Barcos M; Thor AP; Liu E; Koerner F
    Cytometry; 1995 Dec; 22(4):297-306. PubMed ID: 8749780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome.
    Geara FB; Nasr E; Tucker SL; Charafeddine M; Dabaja B; Eid T; Abbas J; Salem Z; Shamseddine A; Issa P; El Saghir N
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):364-9. PubMed ID: 17324529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
    Bradbury BD; Lash TL; Kaye JA; Jick SS
    Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
    Buzdar AU; Singletary SE; Valero V; Booser DJ; Ibrahim NK; Rahman Z; Theriault RL; Walters R; Rivera E; Smith TL; Holmes FA; Hoy E; Frye DK; Manuel N; Kau SW; McNeese MD; Strom E; Thomas E; Hunt K; Ames F; Berry D; Hortobagyi GN
    Clin Cancer Res; 2002 May; 8(5):1073-9. PubMed ID: 12006521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients.
    Haffty BG; Lee C; Philpotts L; Horvath L; Ward B; McKhann C; Tocino I
    Cancer J Sci Am; 1998; 4(1):35-40. PubMed ID: 9467044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma.
    Mayers C; Panzarella T; Tannock IF
    Cancer; 2001 Jun; 91(12):2246-57. PubMed ID: 11413512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
    Katz A; Smith BL; Golshan M; Niemierko A; Kobayashi W; Raad RA; Kelada A; Rizk L; Wong JS; Bellon JR; Gadd M; Specht M; Taghian AG
    J Clin Oncol; 2008 May; 26(13):2093-8. PubMed ID: 18445838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
    Dressler LG; Berry DA; Broadwater G; Cowan D; Cox K; Griffin S; Miller A; Tse J; Novotny D; Persons DL; Barcos M; Henderson IC; Liu ET; Thor A; Budman D; Muss H; Norton L; Hayes DF
    J Clin Oncol; 2005 Jul; 23(19):4287-97. PubMed ID: 15994142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers in node-negative breast cancer: a prospective study.
    Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
    Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.